Terumo Aortic have announced the European limited market release of the RelayPro thoracic stent graft system at the 2018 Charing Cross Symposium (CX; 24–27 April, London, UK).
RelayPro is a low profile, next generation device designed to expand the treatment of thoracic endovascular aortic repair (TEVAR) to patients with smaller access vessels. Utilising the same stent design, material, and Dual Sheath Technology of the proven RelayPlus with a 3 to 4F reduction in outer profile, RelayPro delivers the accuracy, control and confidence of the RelayPlus without compromising device integrity and durability.
RelayPro offers physicians a wide range of diameters, lengths, tapers, and proximal configurations. Available in both Bare Stent and Non-Bare Stent (NBS) versions, RelayPro can be individualised to meet the specific anatomical needs of patients.
Mark Miles, global vice president of Marketing at Terumo Aortic, said: “By combining the proven stent design and material of RelayPlus with a lower outer profile, RelayPro enables percutaneous access to treat a larger patient population. This advancement not only expands patient applicability but will help improve access site complications and ultimately reduce the burden of rising global healthcare costs.”
RelayPro is currently enrolling in multiple trials in US and Japan for treatment of Descending Thoracic Aortic Aneurysms, Acute Complicated Type B Thoracic Aortic Dissection, and Blunt Aortic Trauma.
